Abstract: An apparatus combining a solar tracker and a dual heat source collector includes a heat engine assembly and the solar tracker. The heat engine assembly includes a heat collector, a heat collecting lens, and a heat engine. The heat collector includes a solar heat collecting room and a heat source room. The heat collecting lens is arranged on the heat collector and corresponds to the solar heat collecting room. The heat engine is located in the solar heat collecting room. The solar tracker includes a primary mirror, a secondary mirror, a pivot member, and a driving member. The primary mirror has a first reflective surface and a back surface. The primary mirror has a mounting hole passing through the primary mirror. The secondary mirror is mounted above the primary mirror.

Abstract: An apparatus combining a solar tracker and a dual heat source collector includes a heat engine assembly and the solar tracker. The heat engine assembly includes a heat collector, a heat collecting lens, and a heat engine. The heat collector includes a solar heat collecting room and a heat source room. The heat collecting lens is arranged on the heat collector and corresponds to the solar heat collecting room. The heat engine is located in the solar heat collecting room. The solar tracker includes a primary mirror, a secondary mirror, a pivot member, and a driving member. The primary mirror has a first reflective surface and a back surface. The primary mirror has a mounting hole passing through the primary mirror. The secondary mirror is mounted above the primary mirror.

Abstract: The present disclosure provides dosage forms designed to deliver active pharmaceutical ingredients (APIs) in a controlled release manner. For instance, the present disclosure includes dosage forms with adequate time of onset of action and reduced lag times in the fed state. Such dosage forms find use in a variety of conditions where a rapid onset of action is desired followed by an extended release phase for the active agent, for example in the treatment of ADHD, pain or anxiety. In some cases, the dosage form includes a drug composition including a pharmacologically active agent, a barrier layer covering at least a portion of the drug composition, and a drug layer covering at least a portion of the barrier layer, wherein the drug layer includes the pharmacologically active agent. Related methods of making and administering the disclosed dosage forms are also provided.

Abstract: The present invention provides multi-layer capsules and manufacture methods thereof. Different materials are added in sequence into a capsule to form a multi-layer capsule without diffusion and/or interaction between layers.

Abstract: The present invention provides multi-layer capsules and manufacture methods thereof Different materials are added in sequence into a capsule to form a multi-layer capsule without diffusion and/or interaction between layers.